Menu

Repare Therapeutics Inc. RPTX

Full chart Compare
Set alert

Price alert · RPTX

All alert types
2.65 USD 0.00 (+0.00%)

At closeJan 28, 2026, 4:00 PM EST

2.64 -0.01 -0.37%

After hours · Jan 28, 4:00 PM ET

2.65 Day range 2.65

52-week range unavailable

YTD
+1.92%
1 year
+130.43%

Revenue & Expenses

Other Income → Expenses: $10.27MExpenses → Selling, General & Admin: $29.68MExpenses → Research & Development: $115.94MExpenses → Other Operating Expenses: $1.38MExpenses → Income Tax: $1.44MGross Profit → Expenses: $53.48MRevenue → Gross Profit: $53.48MNet Loss → Expenses: $84.69MOther Income$10.27MGross Profit$53.48MNet Loss$84.69MExpenses$148.44MSelling, General & Admin$29.68MResearch & Development$115.94MOther Operating Expenses$1.38MIncome Tax$1.44MRevenue$53.48M

Latest period ending Dec 31, 2024 · select a line to chart its full history

RPTX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
53.48M51.13M131.83M7.60M135.00K
53.48M51.13M131.83M7.60M135.00K
-93.52M-116.22M-19.80M-108.66M-54.30M
-84.69M-93.80M-29.05M-106.91M-53.42M
-2.00-2.23-0.69-2.83-2.66
RPTX annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
84.72M111.27M159.52M334.43M326.40M
176.51M253.90M364.07M368.71M357.09M
25.38M41.82M84.56M80.29M70.26M
1.93M3.41M5.43M7.31M4.00M
151.13M212.08M279.52M288.42M286.83M
RPTX annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-76.44M-127.16M322.00K-85.80M-6.08M
49.47M78.04M-175.78M-1.68M-9.76M
542.00K842.00K880.00K95.56M247.84M
-26.55M-48.25M-174.91M8.03M231.39M